caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1245579267

Michelle Blankenship

PRACTICEMAYO CLINICSee all providers at this practice →
Nurse PractitionerRochester, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
140
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
6
Brand share
0.0%
Top prescribed drugs
Furosemide40 claims
Levothyroxine Sodium25 claims
Mirtazapine24 claims
Isosorbide Dinitrate22 claims
Spironolactone16 claims
REFERRAL NETWORK

Where Michelle Blankenship's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LA PAZ REGIONAL HOSPITAL INC60130
PEREIRA, BENVINDA2132
MAYO CLINIC HEALTH SYSTEM-SOUTHWEST MINNESOTA REGION1730
BECKMANN, DAVID1155
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Sonora Quest Laboratories Llc
Clinical Laboratory · Phoenix, AZ
51141
LA PAZ REGIONAL HOSPITAL INC4289
PEREIRA, BENVINDA3871
BECKMANN, DAVID1342
CRESPO, JOSE1122
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.